Significant additional funding secured for further development
KWA Public Relations, LLC – October 25, 2024, 14:00 GMT Transcatheter aortic valve is developed with next-generation polymer to improve both durability and biocompatibility ATLANTA, GA, UNITED STATES, October 25, 2024 /EINPresswire.com/ — Todd Tomba, president and CEO, YoungHeartValve, Inc., announced today that the company has received $2.8 million in additional National Institutes of Health […]
Young Heart Valve Awarded Funding Through SBIR Phase 1
In August 2021, Young Heart Valve was awarded over $450,000 to fund our project: Novel Hyaluronan Enhanced Polymeric Trans-Catheter Aortic Valve The long-term goal of this project is to commercialize hyaluronan enhanced polymeric transcatheter aortic valves (HAPTAVs) that have the durability of surgically implanted mechanical valves, do not require life-long anticoagulation, avoid the emerging problems […]
